| Product Code: ETC12973867 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Narcolepsy Drugs Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Narcolepsy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Narcolepsy Drugs Market - Industry Life Cycle |
3.4 Sweden Narcolepsy Drugs Market - Porter's Five Forces |
3.5 Sweden Narcolepsy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Sweden Narcolepsy Drugs Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 Sweden Narcolepsy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Sweden Narcolepsy Drugs Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
3.9 Sweden Narcolepsy Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Narcolepsy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about narcolepsy and its treatment options in Sweden |
4.2.2 Rising prevalence of narcolepsy in the country |
4.2.3 Technological advancements leading to the development of more effective narcolepsy drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Sweden |
4.3.2 High cost associated with narcolepsy drugs |
4.3.3 Limited availability of specialized healthcare professionals for narcolepsy diagnosis and treatment |
5 Sweden Narcolepsy Drugs Market Trends |
6 Sweden Narcolepsy Drugs Market, By Types |
6.1 Sweden Narcolepsy Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Narcolepsy Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Sweden Narcolepsy Drugs Market Revenues & Volume, By Stimulants, 2021 - 2031F |
6.1.4 Sweden Narcolepsy Drugs Market Revenues & Volume, By Wakefulness-Promoting Agents, 2021 - 2031F |
6.1.5 Sweden Narcolepsy Drugs Market Revenues & Volume, By Antidepressants, 2021 - 2031F |
6.1.6 Sweden Narcolepsy Drugs Market Revenues & Volume, By Sodium Oxybate, 2021 - 2031F |
6.1.7 Sweden Narcolepsy Drugs Market Revenues & Volume, By Histamine H3 Receptor Antagonists, 2021 - 2031F |
6.2 Sweden Narcolepsy Drugs Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Sweden Narcolepsy Drugs Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.2.3 Sweden Narcolepsy Drugs Market Revenues & Volume, By Capsule, 2021 - 2031F |
6.2.4 Sweden Narcolepsy Drugs Market Revenues & Volume, By Liquid, 2021 - 2031F |
6.2.5 Sweden Narcolepsy Drugs Market Revenues & Volume, By Suspension, 2021 - 2031F |
6.2.6 Sweden Narcolepsy Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Sweden Narcolepsy Drugs Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Sweden Narcolepsy Drugs Market Revenues & Volume, By Dopamine Regulation, 2021 - 2031F |
6.3.3 Sweden Narcolepsy Drugs Market Revenues & Volume, By Orexin Activation, 2021 - 2031F |
6.3.4 Sweden Narcolepsy Drugs Market Revenues & Volume, By Serotonin Modulation, 2021 - 2031F |
6.3.5 Sweden Narcolepsy Drugs Market Revenues & Volume, By GABA Activation, 2021 - 2031F |
6.3.6 Sweden Narcolepsy Drugs Market Revenues & Volume, By Histamine Regulation, 2021 - 2031F |
6.4 Sweden Narcolepsy Drugs Market, By Patient Group |
6.4.1 Overview and Analysis |
6.4.2 Sweden Narcolepsy Drugs Market Revenues & Volume, By Adults, 2021 - 2031F |
6.4.3 Sweden Narcolepsy Drugs Market Revenues & Volume, By Teenagers, 2021 - 2031F |
6.4.4 Sweden Narcolepsy Drugs Market Revenues & Volume, By Elderly, 2021 - 2031F |
6.4.5 Sweden Narcolepsy Drugs Market Revenues & Volume, By Children, 2021 - 2031F |
6.4.6 Sweden Narcolepsy Drugs Market Revenues & Volume, By All Ages, 2021 - 2031F |
6.5 Sweden Narcolepsy Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Sweden Narcolepsy Drugs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.5.3 Sweden Narcolepsy Drugs Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.4 Sweden Narcolepsy Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.5 Sweden Narcolepsy Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.5.6 Sweden Narcolepsy Drugs Market Revenues & Volume, By Prescription Only, 2021 - 2031F |
7 Sweden Narcolepsy Drugs Market Import-Export Trade Statistics |
7.1 Sweden Narcolepsy Drugs Market Export to Major Countries |
7.2 Sweden Narcolepsy Drugs Market Imports from Major Countries |
8 Sweden Narcolepsy Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to narcolepsy drug treatment |
8.2 Number of clinical trials for new narcolepsy drugs in Sweden |
8.3 Percentage of healthcare facilities offering narcolepsy treatment and services |
9 Sweden Narcolepsy Drugs Market - Opportunity Assessment |
9.1 Sweden Narcolepsy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Sweden Narcolepsy Drugs Market Opportunity Assessment, By Form, 2021 & 2031F |
9.3 Sweden Narcolepsy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Sweden Narcolepsy Drugs Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
9.5 Sweden Narcolepsy Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Narcolepsy Drugs Market - Competitive Landscape |
10.1 Sweden Narcolepsy Drugs Market Revenue Share, By Companies, 2024 |
10.2 Sweden Narcolepsy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here